Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location  Micah.

Similar presentations


Presentation on theme: "Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location  Micah."— Presentation transcript:

1 Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location  Micah J. Hill, D.O., Janelle C. Cooper, M.D., Gary Levy, M.D., Connie Alford, M.D., Kevin S. Richter, Ph.D., Alan H. DeCherney, M.D., Charles L. Katz, M.D., Eric D. Levens, M.D., Erin F. Wolff, M.D.  Fertility and Sterility  Volume 101, Issue 2, Pages e4 (February 2014) DOI: /j.fertnstert Copyright © Terms and Conditions

2 Figure 1 Box and whisker plots of pretreatment and posttreatment oocyte yield, AFC, and FSH values in the surgical and methotrexate groups. Boxes represent the interquartile range, and the line within the boxes represent the median. The vertical lines protruding from the box extend to the minimum and the maximum values of the data set so long as these values do not differ from the median by more than 1.5 times the interquartile range. Outliers from this range are represented by dots. There were no statistically significant differences between pretreatment and posttreatment values within either group. Fertility and Sterility  , e4DOI: ( /j.fertnstert ) Copyright © Terms and Conditions

3 Figure 2 Scatterplots of the change in oocyte yield from pretreatment to posttreatment values plotted against the time between ART cycles in day. (A) Includes all patients in the methotrexate group out to 1,780 days. (B) Includes only patients in the methotrexate group having a repeat ART cycle with 365 days. Fertility and Sterility  , e4DOI: ( /j.fertnstert ) Copyright © Terms and Conditions

4 Supplemental Figure 1 Less than efficiency curve evaluating time between ART cycles and the change in oocyte yield from pretreatment to posttreatment values. The change in oocyte yield was calculated for all values below each time point in increments of 25 days. Patients with <100 days between cycles had an oocyte yield change of +2.8; however, that group consisted of only five patients. Otherwise, there was no postmethotrexate time effect on oocyte yield. Fertility and Sterility  , e4DOI: ( /j.fertnstert ) Copyright © Terms and Conditions

5 Supplemental Figure 2 Scatterplots of the change in AFC yield from pretreatment to posttreatment values plotted against the time between ART cycles in day. (A) Includes all patients in the methotrexate group out to 1,780 days. (B) Includes only patients in the methotrexate group having a repeat ART cycle with 365 days. Fertility and Sterility  , e4DOI: ( /j.fertnstert ) Copyright © Terms and Conditions

6 Supplemental Figure 3 Scatterplots of the change in FSH yield from pretreatment to posttreatment values plotted against the time between ART cycles in days. Patients undergoing repeat ART cycle within 1 year typically did not have repeat FSH testing performed. Fertility and Sterility  , e4DOI: ( /j.fertnstert ) Copyright © Terms and Conditions


Download ppt "Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location  Micah."

Similar presentations


Ads by Google